SEC Filings TLDR

Christopher Hatto, an officer at General Motors Company, has exercised stock options for 15,697 common shares on October 28, 2025. The shares were acquired from the issuer, and the transaction was a cash payment. The aggregate market value of the securities to be sold is $1,089,057.86. Additionally, Hatto has sold a si...

Daniel O'Day, an officer and director of Gilead Sciences, Inc., has filed a Form 144 notice indicating his intention to sell securities. The filing details the sale of 10,000 common shares on October 28, 2025, with an aggregate market value of $1,193,926. Additionally, O'Day has sold 10,000 common shares on September 2...

Michael Hartung, an officer of Flex Ltd., has filed a Form 144 indicating his intention to sell 15,000 shares of Flex Ltd. common stock. The shares are part of a plan adopted on June 16, 2025, and include shares acquired through restricted stock vesting on June 11, 2024 (12,270 shares) and June 14, 2024 (2,730 shares)....

Eric Richard Remer, an officer and director of EverCommerce Inc., has filed a notice of securities to be sold under Rule 144. The filing details transactions involving common stock of EverCommerce Inc. over the past three months. Remer acquired shares through stock awards on multiple dates, including 05/22/2024, 09/01/...

The filing reports that Eleanor Lukens, a former officer of ESAB Corp, exercised stock options for 1,824 shares of common stock on October 28, 2025. The transaction was executed through Fidelity Brokerage Services LLC, and the aggregate market value of the shares was $222,556.27. The filing also confirms that there wer...

The filing details the restricted stock vesting and sale plan for J.E.B. Bolen, an officer of EQT Corp. The plan involves the sale of 1,422 units of common stock, with an aggregate market value of $75,067.38. The securities were acquired through restricted stock vesting transactions between March 8, 2023, and January 1...

Molly Campbell, a director of East West Bancorp Inc, has filed a Form 144 notice indicating her intent to sell 1,345 shares of the company's common stock. The shares were acquired on August 15, 2017, as part of an equity compensation plan. The approximate sale date is set for October 28, 2025, with an aggregate market ...

Kirk E. Kleiser, a director of Catalyst Bancorp, Inc., has filed a Form 144 notice indicating his intention to sell 4,750 shares of the company's common stock. The shares were acquired on October 8, 2021, and are currently held in an account titled 'Kleiser Enterprises Inc.' The sale is expected to take place on Octobe...

The filing details the securities transactions of Christopher Levendos, an officer of Crown Castle Inc. It includes the sale of 1,417 units of Crown Castle Inc. common stock on August 6, 2025, with gross proceeds of $149,961. Additionally, it reports the acquisition of 1,065 units of common stock on February 19, 2023, ...

Tim Hingtgen, former CEO of Community Health Systems, Inc., has filed a notice of intent to sell 532,813 shares of common stock, with an aggregate market value of $2,226,625. The sale is scheduled for October 28, 2025. The shares were acquired through Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) ove...

Liu Chang, an officer and director at Cathay General Bancorp, has filed a Form 144 notice indicating the planned sale of 5,165 common shares acquired through restricted stock lapse. The shares were acquired on April 1, 2025, and the notice was filed on October 28, 2025. The aggregate market value of the shares to be so...

Ellen M Zane, a director of Boston Scientific Corp, has filed a Form 144 indicating the sale of 2,901 shares of common stock. The shares were acquired through a stock grant on May 1, 2025, and were sold on October 28, 2025, with an aggregate market value of $296,591.81. Additionally, Zane sold 9,990 shares in the past ...

Richard M. Schulze, a 10% stockholder of Best Buy Co Inc, has filed a Form 144 to sell 92,293 shares of common stock. The shares were acquired on April 18, 1985, as Founders Shares. The sale is planned for October 28, 2025, with an aggregate market value of $7,649,243.84. In the past three months, Schulze has sold a to...

Todd F Watanabe, an officer of Arcutis Biotherapeutics Inc, has filed a Form 144 notice indicating the intent to sell 40,000 shares of common stock. The shares were acquired through restricted stock vesting on 03/01/2025 and 02/01/2025. The aggregate market value of the shares to be sold is approximately $1,001,032.56....

Juan Jaen, an officer of Arcus Biosciences, Inc., has filed a Form 144 notice indicating his intention to sell 100,000 shares of Class A Common Stock. The shares were acquired on May 29, 2015, in a private transaction with the issuer. The sale is part of a Rule 10b5-1(c) compliant selling plan adopted on August 12, 202...

Robert C. Goeltz II, an officer of Arcus Biosciences, Inc., has modified his 10b5-1 trading plan on February 23, 2024. The plan involves the sale of 5,000 common shares of Arcus Biosciences, Inc., which were acquired on December 15, 2023, through equity compensation. The shares are scheduled to be sold on October 28, 2...

The filing details the securities transactions of Chuck Hastings, a director at Applied Digital Corp. Hastings acquired 200,000 common shares through a private placement on April 1, 2021. The filing also reports recent sales of securities by Hastings in the past three months, including the sale of 30,000 shares on Augu...

The filing details the sale of securities by Mohammad Saidal Mohmand, an officer of Applied Digital Corporation. The securities sold include 100,000 common shares on October 24, 2025, for $3,407,700 and 75,000 common shares on September 3, 2025, for $1,144,500. The securities were acquired as restricted stock on variou...

This filing is a late submission of Form 144 for Stephanie N. Richard, an officer of Ally Financial Inc., due to an administrative error related to sales executed on April 30, 2025. The filing details the sale of 8,000 units of common stock with an aggregate market value of $257,120.80. The securities were acquired as ...

Morgan Sandra Douglass, a director at Allegiant Travel CO, has filed a Form 144 indicating the planned sale of 350 shares of common stock. The shares are set to vest on October 25, 2025, and the sale is expected to occur on October 28, 2025. The aggregate market value of the shares is $22,750. The shares were acquired ...

Joseph Konowiecki, a director of Alignment Healthcare Inc, has filed a Form 144 indicating his intention to sell 25,000 shares of common stock. The shares were acquired through a stock bonus on October 6, 2014, and are set to be sold on October 28, 2025. The aggregate market value of the shares to be sold is approximat...

The filing details the securities transactions of Elinor Mertz, an officer at Airbnb, Inc. The transactions include the acquisition and sale of Class A shares. Mertz acquired shares through various means such as stock option exercises, restricted stock vesting, and ESPP purchases. The acquired shares were purchased on ...

Sofinnova Crossover I SLP, an affiliate of Abivax S.A., has filed a Form 144 with the SEC indicating its intention to sell 1.2 million American Depositary Shares (ADS) of Abivax S.A. The shares were acquired during the company's IPO on October 20, 2023. The sale is planned to occur around October 28, 2025, with an aggr...

Baruch Niran, an officer of AudioCodes Ltd, has adopted a Rule 10b5-1 trading plan on November 20, 2024, to sell securities. The plan involves the sale of 5,625 ordinary shares with an aggregate market value of $50,906.25, scheduled for October 28, 2025. The securities to be sold were acquired as Restricted Stock Units...

Aldema Lior, an officer of AudioCodes Ltd, has adopted a 10b5-1 sale plan on 11/15/2024, which outlines the sale of securities. The plan includes the sale of 8,439 Ordinary shares with an aggregate market value of $76,372.95, scheduled for approximately 10/28/2025. The securities to be sold were acquired through Restri...